Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
March 20, 2023
Fred Hutch hosts inaugural Dr. E. Donnall Thomas Symposium
Event draws leading researchers in transplantation, gene and cell therapy
Solid tumors use a type of T cell as a shield against immune attack
Discovery in head and neck cancers may open door for targeted immune-boosting drugs
Dr. Brenda Sandmaier named president of American Society for Transplantation and Cellular Therapy
Transplant immunotherapy physician-scientist will serve 2022-2023 term
Dr. Michael Linenberger honored for contributions to apheresis medicine
Presidential Award from American Society for Apheresis recognizes hematologist’s two decades of service
How does leukemia escape from immunotherapy?
Single-cell sequencing tech enables deep dive into mysterious results, sets stage for future improvements
Hopes and predictions for 2022
Hutch researchers look ahead to an increase in cancer screening, improved vaccines and greater trust in science
Highlights of Fred Hutch science in 2021
From COVID-19 to cancer, Hutch scientists pursued new ideas to save lives
Science Says: Fearless science
Immunotherapy, equity in colorectal cancer and the latest on the COVID-19 virus's omicron variant
Dr. Robert Bradley named scientific director of Fred Hutch Translational Data Science Integrated Research Center
Computational biologist will lead efforts to integrate data science in bench-to-bedside cancer research
Science Says: Cracking the code in solid tumors
How scientists are developing targeted new therapies for cancers of the breast, lung, stomach and more
5 reasons why a cancer research center has virology expertise
Pathogens can cause diseases, the immune system can fight them
What's next for T-cell therapies: Q&A with Dr. Stanley Riddell
After approval of latest cellular therapy for non-Hodgkin lymphoma, the immunologist looks ahead
Advances in blood disorders research continue despite COVID-19
Expanding use of CAR T-cell therapies, gene editing lead to insights at virtual annual meeting of the American Society of Hematology
Fred Hutch Evergreen Fund awards six grants to promising projects
Scientists receive up to $200K to boost research for projects deemed to have partnership potential
A path opens for precise analyses of breast cancer proteins
Paulovich lab runs CLIA-cleared tests to find patients appropriate for new HER2-targeted therapies
Dr. Hans-Peter Kiem elected vice president of American Society of Gene & Cell Therapy
After serving 1 year as vice president, Kiem will serve as president-elect and president of the society
Science on the horizon
Fred Hutch experts make predictions for science trends, advances in 2020
Fred Hutch science and research highlights 2019
Articles showcasing some of the most significant advances in immunotherapy, cell biology and more
New CAR T cells with synthetic ankyrin repeats
From the Riddell Laboratory, Clinical Research Division
Targeting renal cell carcinoma with transgenic T cell therapy
From the Tykodi and Warren laboratories, Clinical Research Division